Prostate Cancer — Proceedings from a Multitumor Symposium in Partnership with Florida Cancer Specialists & Research Institute
Research To Practice | Oncology Videos
00:00
Comparing AR Pathway Inhibitors
Panel prefers darolutamide for tolerability and minimal CNS effects; all ARPIs remain generally well tolerated.
Play episode from 21:58
Transcript
